Oral health and the oral microbiome in pancreatic cancer: An overview of epidemiological studies

Cancer Journal (United States)

Volumn 23, Issue 6, 2017, Pages 310-314

  Bracci, Paige M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dysbiosis; epidemiology; human microbiome; oral health; pancreatic neoplasms; periodontal disease

Indexed keywords

ALCOHOL CONSUMPTION; ATHEROSCLEROSIS; BIBLIOGRAPHIC DATABASE; BODY MASS; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CHRONIC PERIODONTITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FOLLOW UP; GINGIVITIS; HEALTH SURVEY; HIGH THROUGHPUT SEQUENCING; HUMAN; MICROBIAL DIVERSITY; MONOZYGOTIC TWINS; MOUTH FLORA; MULTIMODALITY CANCER THERAPY; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PANCREAS CANCER; PERIODONTAL DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; CANCER REGISTRY; HEALTH; META ANALYSIS; MICROBIOLOGY; MICROFLORA; MOUTH; PANCREAS TUMOR;

BACTERIUM ANTIBODY;

ANTIBODIES, BACTERIAL; HUMANS; MICROBIOTA; MOUTH; ORAL HEALTH; PANCREATIC NEOPLASMS; PERIODONTAL DISEASES; POPULATION SURVEILLANCE; SEER PROGRAM; TOOTH LOSS;

EID: 85037031888     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0000000000000287     Document Type: Review

References (38)

1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2014. Bethesda, MD: National Cancer Institute; 2017. Available at: https://seer.cancer.gov/archive/csr/1975-2012/results-merged/sect-22-pancreas.pdf. Accessed May 30, 2017.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017; 67: 7-30.
3. Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014; 74: 2913-2921.
4. Amundadottir LT. Pancreatic cancer genetics. Int J Biol Sci. 2016; 12: 314-325.
5. How KY, Song KP, Chan KG. Porphyromonas gingivalis: an overview of periodontopathic pathogen below the gum line. Front Microbiol. 2016; 7: 53.
6. Schenkein HA, Loos BG. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Periodontol. 2013; 84(4-s): S51-S69.
7. Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis. 2012; 33: 1055-1058.
8. Ansai T, Takata Y, Yoshida A, et al. Association between tooth loss and orodigestive cancer mortality in an 80-year-old community-dwelling Japanese population: a 12-year prospective study. BMC Public Health. 2013; 13: 814.
9. Arora M, Weuve J, Fall K, et al. An exploration of shared genetic risk factors between periodontal disease and cancers: a prospective co-Twin study. Am J Epidemiol. 2010; 171: 253-259.
10. Chang JS, Tsai CR, Chen LT, et al. Investigating the association between periodontal disease and risk of pancreatic cancer. Pancreas. 2016; 45: 134-141.
11. Hiraki A, Matsuo K, Suzuki T, et al. Teeth loss and risk of cancer at 14 common sites in Japanese. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1222-1227.
12. Huang J, Roosaar A, Axéll T, et al. A prospective cohort study on poor oral hygiene and pancreatic cancer risk. Int J Cancer. 2016; 138: 340-347.
13. Hujoel PP, Drangsholt M, Spiekerman C, et al. An exploration of the periodontitis-cancer association. Ann Epidemiol. 2003; 13: 312-316.
14. Michaud DS, Joshipura K, Giovannucci E, et al. A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J Natl Cancer Inst. 2007; 99: 171-175.
15. Michaud DS, Liu Y, Meyer M, et al. Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study. Lancet Oncol. 2008; 9: 550-558.
16. Michaud DS, Kelsey KT, Papathanasiou E, et al. Periodontal disease and risk of all cancers among male never smokers: an updated analysis of the Health Professionals Follow-up Study. Ann Oncol. 2016; 27: 941-947.
17. Stolzenberg-Solomon RZ, Dodd KW, Blaser MJ, et al. Tooth loss, pancreatic cancer, and Helicobacter pylori. Am J Clin Nutr. 2003; 78: 176-181.
18. Wen BW, Tsai CS, Lin CL, et al. Cancer risk among gingivitis and periodontitis patients: a nationwide cohort study. QJM. 2014; 107: 283-290.
19. Maisonneuve P, Amar S, Lowenfels AB. Periodontal disease, edentulism, and pancreatic cancer: a meta-Analysis. Ann Oncol. 2017; 28: 985-995.
20. Michaud DS, Fu Z, Shi J, et al. Periodontal disease, tooth loss, and cancer risk. Epidemiol Rev. 2017; 39: 49-58.
21. Hwang IM, Sun LM, Lin CL, et al. Periodontal disease with treatment reduces subsequent cancer risks. QJM. 2014; 107: 805-812.
22. Chen T, Yu WH, Izard J, et al. The Human Oral Microbiome Database: aWeb accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford). 2010; 2010.
23. Serrae Silva Filho W, Casarin RC, Nicolela EL Jr, et al. Microbial diversity similarities in periodontal pockets and atheromatous plaques of cardiovascular disease patients. PLoS One. 2014; 9: e109761.
24. Mitsuhashi K, Nosho K, Sukawa Y, et al. Association of Fusobacterium species in pancreatic cancer tissues with molecular features and prognosis. Oncotarget. 2015; 6: 7209.
25. Michaud DS, Izard J, Wilhelm-Benartzi CS, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut. 2013; 62: 1764-70.
26. Fan X, Alekseyenko AV, Wu J, et al. Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study [published online ahead of print October 14, 2016]. Gut. 2016.
27. Lin IH, Wu J, Cohen SM, et al. Abstract 101: pilot study of oral microbiome and risk of pancreatic cancer. Cancer Res. 2013; 73(suppl 8): 101-101.
28. Farrell JJ, Zhang L, Zhou H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut. 2012; 61: 582-588.
29. Torres PJ, Fletcher EM, Gibbons SM, et al. Characterization of the salivary microbiome in patients with pancreatic cancer. PeerJ. 2015; 3: e1373.
30. Olson SH, Satagopan J, Xu Y, et al. The oral microbiota in patients with pancreatic cancer, patients with IPMNs, and controls: a pilot study [published online ahead of print July 31, 2017]. Cancer Causes Control. 2017.
31. Han YW, Wang X. Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J Dent Res. 2013; 92: 485-491.
32. Atanasova KR, Yilmaz O. Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol Oral Microbiol. 2014; 29: 55-66.
33. Ahn J, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control. 2012; 23: 399-404.
34. Hayashi C, Gudino CV, Gibson FC III, et al. Review: pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways: pathogen-induced inflammation. Mol Oral Microbiol. 2010; 25: 305-316.
35. Hong BY, Araujo MVF, Strausbaugh LD, et al. Microbiome profiles in periodontitis in relation to host and disease characteristics. PLoS One. 2015; 10: e0127077.
36. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004; 4: 499-511.
37. Vaz J. Intervention on Toll-like receptors in pancreatic cancer. World J Gastroenterol. 2014; 20: 5808.
38. Ochi A, Nguyen AH, Bedrosian AS, et al. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via TH2 cells. J ExpMed. 2012; 209: 1671-1687.